Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection

The effect of highly active antiretroviral therapy (HAART) on the natural history of anal squamous intraepithelial lesions (ASIL)-the likely anal cancer precursor-and anal human papillomavirus (HPV) infection is unknown. ASIL severity and level of anal HPV DNA were evaluated among HIV-positive men w...

Full description

Saved in:
Bibliographic Details
Published inJournal of acquired immune deficiency syndromes (1999) Vol. 28; no. 5; p. 422
Main Authors Palefsky, J M, Holly, E A, Ralston, M L, Da Costa, M, Bonner, H, Jay, N, Berry, J M, Darragh, T M
Format Journal Article
LanguageEnglish
Published United States 15.12.2001
Subjects
Online AccessGet more information

Cover

Loading…
Abstract The effect of highly active antiretroviral therapy (HAART) on the natural history of anal squamous intraepithelial lesions (ASIL)-the likely anal cancer precursor-and anal human papillomavirus (HPV) infection is unknown. ASIL severity and level of anal HPV DNA were evaluated among HIV-positive men who have sex with men (MSM) for at least 6 months before initiation of HAART. The results were compared with those from a 6-month period after initiation of HAART. Anal swabs for cytology and HPV studies were obtained, followed by high-resolution anoscopy and biopsy. Among men whose most severe pre-HAART diagnosis was atypical squamous cells of undetermined significance or low-grade ASIL, 18% (confidence interval [CI], 6-31%, 7 of 38) progressed and 21% (CI, 8-34%, 8 of 38) regressed 6 months after starting HAART. Seventeen percent (CI, 0-38%, 2 of 12) of study subjects who began with a normal diagnosis developed ASIL. Only 4% (CI, 0-10%, 1 of 28) of study subjects with high-grade ASIL regressed to normal. There was no reduction in the proportion of study subjects who tested positive for HPV DNA or HPV DNA levels after HAART initiation. The ASIL and HPV data were similar to those of the pre-HAART comparison period. These results indicate that HAART has little effect on either ASIL or HPV in the first 6 months after HAART initiation.
AbstractList The effect of highly active antiretroviral therapy (HAART) on the natural history of anal squamous intraepithelial lesions (ASIL)-the likely anal cancer precursor-and anal human papillomavirus (HPV) infection is unknown. ASIL severity and level of anal HPV DNA were evaluated among HIV-positive men who have sex with men (MSM) for at least 6 months before initiation of HAART. The results were compared with those from a 6-month period after initiation of HAART. Anal swabs for cytology and HPV studies were obtained, followed by high-resolution anoscopy and biopsy. Among men whose most severe pre-HAART diagnosis was atypical squamous cells of undetermined significance or low-grade ASIL, 18% (confidence interval [CI], 6-31%, 7 of 38) progressed and 21% (CI, 8-34%, 8 of 38) regressed 6 months after starting HAART. Seventeen percent (CI, 0-38%, 2 of 12) of study subjects who began with a normal diagnosis developed ASIL. Only 4% (CI, 0-10%, 1 of 28) of study subjects with high-grade ASIL regressed to normal. There was no reduction in the proportion of study subjects who tested positive for HPV DNA or HPV DNA levels after HAART initiation. The ASIL and HPV data were similar to those of the pre-HAART comparison period. These results indicate that HAART has little effect on either ASIL or HPV in the first 6 months after HAART initiation.
Author Darragh, T M
Bonner, H
Da Costa, M
Holly, E A
Palefsky, J M
Berry, J M
Ralston, M L
Jay, N
Author_xml – sequence: 1
  givenname: J M
  surname: Palefsky
  fullname: Palefsky, J M
  email: joelp@medicine.ucsf.edu
  organization: Department of Laboratory Medicine, University of California, San Francisco, San Francisco, California 94143, USA. joelp@medicine.ucsf.edu
– sequence: 2
  givenname: E A
  surname: Holly
  fullname: Holly, E A
– sequence: 3
  givenname: M L
  surname: Ralston
  fullname: Ralston, M L
– sequence: 4
  givenname: M
  surname: Da Costa
  fullname: Da Costa, M
– sequence: 5
  givenname: H
  surname: Bonner
  fullname: Bonner, H
– sequence: 6
  givenname: N
  surname: Jay
  fullname: Jay, N
– sequence: 7
  givenname: J M
  surname: Berry
  fullname: Berry, J M
– sequence: 8
  givenname: T M
  surname: Darragh
  fullname: Darragh, T M
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11744829$$D View this record in MEDLINE/PubMed
BookMark eNo1kM9OwzAMxnMYYn_gFVBeoJCkSdMe0TRg0iQucJ68NqFBbVKSdFJfhOclZXCy_fn32ZbXaGGdVQhhSu4pqeQDIYQzUZCMEUIpo4JkSSL5Aq2oYCLjNBdLtA7hM_ULzqtrtKRUcl6yaoW-d1qrOmKncWs-2m7CUEdzVhhsNF5F787GQ4djqzwME3Z2TrGFOM5ya0J0fprtYFMdvkbo3RiwsdGDGkyCO5ManQrG2ZCo5kK2Yw8WDzCYrnM9pC2_rvmYBN6gKw1dULd_cYPen3Zv25fs8Pq83z4esppznmeiPJW0bqoTsIoBbYRWjVZCMCo18FqUWlJZkIJxQkoqZc0KQQsmhFSkYSJnG3R3mTuMp141x8GbHvx0_H8Q-wFBGmy0
CitedBy_id crossref_primary_10_1002_ijc_30579
crossref_primary_10_1007_s11904_005_0008_4
crossref_primary_10_1007_s10350_006_0873_y
crossref_primary_10_1071_SH11167
crossref_primary_10_1097_01_aids_0000181012_62385_4a
crossref_primary_10_1016_j_jaad_2014_06_045
crossref_primary_10_1016_S1470_2045_12_70080_3
crossref_primary_10_1097_QAD_0000000000000603
crossref_primary_10_1016_j_pvr_2019_100184
crossref_primary_10_1097_00001622_200309000_00007
crossref_primary_10_1007_s11904_013_0170_z
crossref_primary_10_1097_QAD_0000000000000160
crossref_primary_10_1086_381681
crossref_primary_10_1016_j_soc_2003_12_003
crossref_primary_10_1007_s10350_006_0658_3
crossref_primary_10_4137_CPath_S501
crossref_primary_10_1016_j_det_2006_06_010
crossref_primary_10_1016_j_jaad_2004_11_060
crossref_primary_10_1097_OLQ_0b013e3181c9c23f
crossref_primary_10_1157_13095527
crossref_primary_10_1093_infdis_jit028
crossref_primary_10_1016_S0889_8588_03_00039_X
crossref_primary_10_1590_S0101_98802010000400002
crossref_primary_10_1053_j_scrs_2005_03_002
crossref_primary_10_1016_S1473_3099_05_70323_6
crossref_primary_10_1111_j_1463_1318_2010_02494_x
crossref_primary_10_1007_s10350_008_9270_z
crossref_primary_10_1007_s11904_005_0007_5
crossref_primary_10_1136_sextrans_2021_055271
crossref_primary_10_1002_cncy_20126
crossref_primary_10_1007_s11908_010_0090_7
crossref_primary_10_1097_QAD_0b013e3283319184
crossref_primary_10_1097_01_OLQ_0000109515_75864_2B
crossref_primary_10_1097_01_qai_0000159669_80207_12
crossref_primary_10_1371_journal_pone_0084030
crossref_primary_10_1097_QAD_0b013e328339e592
crossref_primary_10_1371_journal_pone_0035983
crossref_primary_10_1097_01_olq_0000162366_60245_02
crossref_primary_10_2217_17455057_4_4_357
crossref_primary_10_1258_ijsa_2007_007224
crossref_primary_10_1007_s00105_006_1239_z
crossref_primary_10_1177_2325957416682302
crossref_primary_10_1093_cid_cir064
crossref_primary_10_1097_IPC_0b013e3181b28937
crossref_primary_10_1590_S0101_98802009000300018
crossref_primary_10_1111_j_1468_1293_2009_00737_x
crossref_primary_10_1002_lsm_22062
crossref_primary_10_1096_fj_03_0946fje
crossref_primary_10_1111_j_1440_0960_2007_00369_x
crossref_primary_10_1080_2162402X_2015_1128612
crossref_primary_10_1016_S0168_1702_02_00189_2
crossref_primary_10_1002_dc_20110
crossref_primary_10_1177_135965350400900117
crossref_primary_10_1590_S0101_98802008000100010
crossref_primary_10_1590_S0037_86822007000300007
crossref_primary_10_1002_dc_21201
crossref_primary_10_1016_S0889_8588_03_00047_9
crossref_primary_10_1097_OLQ_0000000000000145
crossref_primary_10_1097_QCO_0b013e328334fe5a
crossref_primary_10_1590_S0102_86502011000600019
crossref_primary_10_1097_QAD_0b013e3281c61201
crossref_primary_10_1016_j_jasc_2023_11_002
crossref_primary_10_1097_01_pas_0000208283_14044_a9
crossref_primary_10_1097_01_aids_0000226955_02719_26
crossref_primary_10_1007_s11904_014_0254_4
crossref_primary_10_1097_01_TP_0000046943_35335_18
crossref_primary_10_1177_154405910408300212
crossref_primary_10_1097_01_tp_0000279190_96029_77
crossref_primary_10_1097_01_ogx_0000221010_82943_8c
crossref_primary_10_1007_s11908_005_0039_4
crossref_primary_10_1111_j_1365_2230_2009_03759_x
crossref_primary_10_1590_S1516_31802007000500009
crossref_primary_10_1089_apc_2010_0233
crossref_primary_10_1097_COH_0b013e32831a7246
crossref_primary_10_1111_j_1525_1470_2010_01103_x
crossref_primary_10_1158_1055_9965_EPI_08_1141
crossref_primary_10_1097_QAD_0b013e32835ad2cb
crossref_primary_10_1016_j_gtc_2007_08_001
crossref_primary_10_1007_s11904_008_0013_5
crossref_primary_10_1016_j_jss_2005_02_017
crossref_primary_10_1097_QCO_0b013e3283213080
crossref_primary_10_1007_s10350_004_0889_0
crossref_primary_10_1097_QAD_0000000000000537
crossref_primary_10_1016_j_dld_2015_01_150
crossref_primary_10_1097_QAD_0b013e3283023f78
crossref_primary_10_1097_QAI_0b013e31817aebfe
crossref_primary_10_1097_DCR_0000000000001384
crossref_primary_10_1097_01_qco_0000200295_30285_13
crossref_primary_10_1097_QAI_0b013e318282a189
crossref_primary_10_1590_S0101_98802009000200015
crossref_primary_10_1157_13123038
crossref_primary_10_1097_QAI_0b013e3182968f87
crossref_primary_10_1007_s11904_015_0276_6
crossref_primary_10_1086_505219
crossref_primary_10_1016_j_jaad_2004_11_026
crossref_primary_10_1007_s11904_009_0018_8
crossref_primary_10_2217_fvl_13_69
crossref_primary_10_1590_S0102_86502012001000009
crossref_primary_10_1258_jms_2009_009058
crossref_primary_10_1097_00002030_200309260_00021
crossref_primary_10_1016_S1730_1270_10_60052_5
crossref_primary_10_1053_scrs_2003_00023X
crossref_primary_10_1002_dc_21242
crossref_primary_10_1177_154407370601900120
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1097/00042560-200112150-00003
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 11744829
Genre Research Support, U.S. Gov't, P.H.S
Journal Article
Comparative Study
GrantInformation_xml – fundername: NCRR NIH HHS
  grantid: 5 M01-RR-00079
– fundername: NCI NIH HHS
  grantid: R01CA54053
GroupedDBID ---
.-D
.GJ
.XZ
.Z2
01R
0R~
1J1
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
77Y
7O~
8L-
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AARTV
AASOK
AAXQO
ABBUW
ABDIG
ABIVO
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACIJW
ACILI
ACOAL
ACPRK
ACWDW
ACWRI
ACXNZ
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AFDTB
AFEXH
AFRAH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
ALKUP
ALMA_UNASSIGNED_HOLDINGS
AMJPA
AMNEI
AWKKM
BKOMP
BOYCO
BQLVK
BS7
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DUNZO
E.X
EBS
ECM
EIF
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FRJ
FRP
FW0
H0~
HZ~
IKREB
IKYAY
IN~
JF9
JG8
JK3
JK8
K8S
KD2
KMI
L-C
NPM
N~7
N~B
N~M
O9-
OAG
OAH
OCUKA
ODA
ODMTH
OHH
OHYEH
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
R58
RLZ
RXW
S4R
S4S
T8P
TAE
TEORI
V2I
VVN
W2D
W3M
WOQ
WOW
X3V
X3W
XJT
XXN
XYM
YHZ
YOC
ZGI
ZXP
ZZMQN
ID FETCH-LOGICAL-c4443-58b81cd9ba292a1d5fedfe55217fa4c58f71760624008177c265162557e0d2532
ISSN 1525-4135
IngestDate Wed Feb 19 02:35:06 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4443-58b81cd9ba292a1d5fedfe55217fa4c58f71760624008177c265162557e0d2532
PMID 11744829
ParticipantIDs pubmed_primary_11744829
PublicationCentury 2000
PublicationDate 2001-December-15
PublicationDateYYYYMMDD 2001-12-15
PublicationDate_xml – month: 12
  year: 2001
  text: 2001-December-15
  day: 15
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of acquired immune deficiency syndromes (1999)
PublicationTitleAlternate J Acquir Immune Defic Syndr
PublicationYear 2001
SSID ssj0016449
Score 2.0936291
Snippet The effect of highly active antiretroviral therapy (HAART) on the natural history of anal squamous intraepithelial lesions (ASIL)-the likely anal cancer...
SourceID pubmed
SourceType Index Database
StartPage 422
SubjectTerms Adult
Aged
Anal Canal - pathology
Anal Canal - virology
Anti-HIV Agents - therapeutic use
Antiretroviral Therapy, Highly Active
Anus Neoplasms - drug therapy
Anus Neoplasms - pathology
Cohort Studies
Homosexuality, Male
Humans
Male
Middle Aged
Neoplasms, Squamous Cell - drug therapy
Neoplasms, Squamous Cell - pathology
Papillomaviridae
Papillomavirus Infections - drug therapy
Papillomavirus Infections - pathology
Title Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection
URI https://www.ncbi.nlm.nih.gov/pubmed/11744829
Volume 28
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELUWkCouiEL5KG3lAzeUam3sfBwruhVaaSuEQOKGnNiWkEI2QBYJfgg_jl_DjO3sZrdQlV6iKE6ym8zTeGY874WQfa0VpBV5ERnJdSQypSPFlY0g9IDpuZBFbJDgPPodH5-L4YW86PWeO11Lkyb_Xjy-yiv5H6vCMbArsmTfYdnpTeEA7IN9YQsWhu0_2ThID2O8Bzl2-eCUMe5xQaABT9ZgtQD5955j9RDWBQ6clidSIJ1CiFthVxiT3t1MFBYCUELiVpka2RolFtRLc-fa5byuK17pKv-1qq_Kcnyt4Fcms7au6o14VxXYdAzx7RVSUpCuheIVjvnZyiZ42SgIJjv1iROYwWyo8A47tdv2G9mDWTX2FF54ywY4mBa1fypweiFIHs0VORg2jHiaZ-uXuYxgvpVdx83TDkBlxwsLT3X-Y3bwqsN956jiPkKJobiGo9Y7pYWmA5r62qGGQcomUv_Ufx9d0O1uh5bIEmQw-ElWrCOF9S2IQjOn5BseK_SYBTnRV_8eytuGWy6kQC4UOlsna8Gm9IcH5EfSM9UG-TAKXRqb5Mnjko4t9bikHpd0Hpc04JKOK9ylAZc04BIvR7TRFpd0AZc04BLO0v5Mh0s6j0s6xeUncv5rcHZ0HIXvf0SFEOIwkmmeskJnueIZV0xLa7Q1EgLOxCrwI6lNWAIJOLZBpyxJCh5LBvm8TExfc3nIt8hyNa7MDqGJERkHpyQkU0LHmUpMnAqbG6tZP07lLtn2b_Sy9iIvl-27_vzmyB5ZnUH1C1mxAHLzFULUJv_mrP0CEZuSFw
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+highly+active+antiretroviral+therapy+on+the+natural+history+of+anal+squamous+intraepithelial+lesions+and+anal+human+papillomavirus+infection&rft.jtitle=Journal+of+acquired+immune+deficiency+syndromes+%281999%29&rft.au=Palefsky%2C+J+M&rft.au=Holly%2C+E+A&rft.au=Ralston%2C+M+L&rft.au=Da+Costa%2C+M&rft.date=2001-12-15&rft.issn=1525-4135&rft.volume=28&rft.issue=5&rft.spage=422&rft_id=info:doi/10.1097%2F00042560-200112150-00003&rft_id=info%3Apmid%2F11744829&rft_id=info%3Apmid%2F11744829&rft.externalDocID=11744829
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1525-4135&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1525-4135&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1525-4135&client=summon